Wyeth Receives FDA Approval Of Protonix For Delayed Release Oral Suspension

Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), announced that the U.S. Food and Drug Administration (FDA) has approved Protonix (pantoprazole sodium) For Delayed-Release Oral Suspension, a new addition to the Protonix family of prescription medications. ...

Write comment to this article:

Subject:

Name:

email or site:

Code: